O'Keefe Stevens Advisory’s Quest Diagnostics DGX Stock Holding History

O'Keefe Stevens Advisory’s Portfolio DGX Stock Details DGX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$397K	Hold	1,875	–	–	0.08%	60
2026 Q1	$367K	Hold	1,875	–	–	0.09%	60
2025 Q4	$325K	Hold	1,875	–	–	0.08%	54
2025 Q3	$357K	Sell	1,875 -625	-25%	-$111K	0.1%	53
2025 Q2	$449K	Hold	2,500	–	–	0.13%	51
2025 Q1	$423K	Hold	2,500	–	–	0.14%	49
2024 Q4	$377K	Hold	2,500	–	–	0.12%	55
2024 Q3	$388K	Hold	2,500	–	–	0.12%	55
2024 Q2	$342K	Hold	2,500	–	–	0.11%	45
2024 Q1	$333K	Hold	2,500	–	–	0.11%	40
2023 Q4	$345K	Hold	2,500	–	–	0.14%	37
2023 Q3	$305K	Hold	2,500	–	–	0.14%	34
2023 Q2	$351K	Hold	2,500	–	–	0.15%	35
2023 Q1	$354K	Hold	2,500	–	–	0.17%	31
2022 Q4	$391K	Hold	2,500	–	–	0.23%	30
2022 Q3	$307K	Hold	2,500	–	–	0.21%	30
2022 Q2	$332K	Hold	2,500	–	–	0.2%	30
2022 Q1	$342K	Hold	2,500	–	–	0.17%	29
2021 Q4	$433K	Hold	2,500	–	–	0.2%	31
2021 Q3	$363K	Hold	2,500	–	–	0.2%	33
2021 Q2	$330K	Hold	2,500	–	–	0.18%	33
2021 Q1	$319K	Hold	2,500	–	–	0.2%	31
2020 Q4	$298K	Hold	2,500	–	–	0.2%	35
2020 Q3	$286K	Hold	2,500	–	–	0.22%	35
2020 Q2	$285K	Buy	+2,500	New	+$265K	0.25%	30
2019 Q4	$264K	Hold	2,500	–	–	0.2%	36
2019 Q3	$268K	Hold	2,500	–	–	0.21%	37
2019 Q2	$255K	Hold	2,500	–	–	0.19%	38
2019 Q1	$225K	Hold	2,500	–	–	0.17%	38
2018 Q4	$208K	Hold	2,500	–	–	0.19%	37
2018 Q3	$270K	Hold	2,500	–	–	0.19%	36
2018 Q2	$275K	Hold	2,500	–	–	0.22%	33
2018 Q1	$251K	Hold	2,500	–	–	0.22%	40
2017 Q4	$246K	Hold	2,500	–	–	0.22%	39
2017 Q3	$234K	Buy	+2,500	New	+$265K	0.22%	41

Other funds holding DGX

AIM

Artemis Investment Management Edinburgh, United Kingdom $11.2B AUM 80.72% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return

ECSS

Eurizon Capital SGR SpA Milan $37.3B AUM

Eastern Bank Boston, Massachusetts $6.53B AUM 30.05% 1-Year Est. Return

CPC

Cookson Peirce & Co Pittsburgh, Pennsylvania $3.04B AUM 94.11% 1-Year Est. Return

AIM

Achmea Investment Management Zeist, Netherlands $4B AUM 31.99% 1-Year Est. Return

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

AAMU

AEGON Asset Management (UK) Edinburgh, United Kingdom $9.38B AUM 48.94% 1-Year Est. Return

AAIS

ABN AMRO Investment Solutions Paris Cedex 008 $11.5B AUM 32.2% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

O'Keefe Stevens Advisory's DGX Position: Q2 2026 in Review

O'Keefe Stevens Advisory held its Quest Diagnostics (DGX) position steady in Q2 2026 at 1,875 shares worth $397K. The position accounts for 0.08% of the portfolio, ranked #60.

O'Keefe Stevens Advisory first reported a position in DGX in Q3 2017 and has held it in 35 quarters since. The position peaked at $449K in Q2 2025. 405 funds tracked by Wall St. Rank hold DGX as of Q2 2026.

O'Keefe Stevens Advisory held 1,875 shares of Quest Diagnostics worth $397K as of Q2 2026.
O'Keefe Stevens Advisory left its Quest Diagnostics share count unchanged in Q2 2026.
Quest Diagnostics made up 0.08% of O'Keefe Stevens Advisory's portfolio in Q2 2026, its #60 holding.
O'Keefe Stevens Advisory first reported a position in Quest Diagnostics in Q3 2017 and has held it in 35 quarters since.
O'Keefe Stevens Advisory's Quest Diagnostics position peaked at $449K in Q2 2025.
405 funds tracked by Wall St. Rank held Quest Diagnostics as of Q2 2026.

Based on O'Keefe Stevens Advisory's 13F filing for Q2 2026, filed 13 Jul 2026.